Ratings Paramount Bed Holdings Co., Ltd.

Equities

7817

JP3781620004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,652 ^JPY	+0.91%		+1.03%	-4.29%

Feb. 08	Tranche Update on Paramount Bed Holdings Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	CI
Feb. 08	Paramount Bed Holdings Co., Ltd.'s Equity Buyback announced on February 7, 2024 has closed with 900,000 shares, representing 1.54% for ¥2,398.5 million.	CI

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Weaknesses

The company's earnings growth outlook lacks momentum and is a weakness.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	ESG Refinitiv
PARAMOUNT BED HOLDINGS CO., LTD.	-4.29%	967M	-
ABBOTT LABORATORIES	-2.31%	187B	C+
MEDTRONIC PLC	-3.20%	106B	C
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B	A
DEXCOM, INC.	+0.20%	49.45B	B-
CENCORA, INC.	+17.29%	48B	B-
HOYA CORPORATION	+4.06%	40.84B	B+
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B	A-
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B	B
TERUMO CORPORATION	+12.96%	24.62B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes